Tags

Type your tag names separated by a space and hit enter

Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases.
Arthritis Rheum. 2001 Jul; 44(7):1663-6.AR

Abstract

OBJECTIVE

To describe a series of systemic sclerosis (SSc) patients with the unusual combination of scleroderma renal crisis (SRC) and pulmonary hypertension (PHT) without interstitial lung disease.

METHODS

The medical records of 2,459 SSc patients in the University of Pittsburgh Scleroderma Databank first evaluated between 1972 and 1999 were reviewed.

RESULTS

Eleven patients (0.45%) had both SRC and PHT. All had been evaluated since 1979, when angiotensin-converting enzyme (ACE) inhibitor therapy for SRC became available. Seven had SSc with limited cutaneous involvement, and 4 had SSc with diffuse cutaneous involvement. SRC occurred first in all patients except 1, in whom the onsets of SRC and PHT were simultaneous. SRC preceded PHT by a mean of 4.3 years. Four patients had anti-Th/To antibody, 5 had anti-RNA polymerase III antibody, 2 had anti-U3 RNP antibody, and none had anticentromere or antitopoisomerase I antibody. Ten of the 11 patients died, 8 from PHT. Ten patients were being treated with ACE inhibitor drugs when PHT developed.

CONCLUSION

In SSc, SRC and PHT are not mutually exclusive complications. SSc patients surviving SRC who have serum antibodies to Th/To, RNA polymerase III, or U3 RNP are at increased risk to develop PHT. ACE inhibitor therapy did not prevent the development of PHT.

Authors+Show Affiliations

Ankara Numune Education and Research Hospital, Canyaka-Ankara, Turkey.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

11465718

Citation

Gündüz, O H., et al. "Systemic Sclerosis With Renal Crisis and Pulmonary Hypertension: a Report of Eleven Cases." Arthritis and Rheumatism, vol. 44, no. 7, 2001, pp. 1663-6.
Gündüz OH, Fertig N, Lucas M, et al. Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases. Arthritis Rheum. 2001;44(7):1663-6.
Gündüz, O. H., Fertig, N., Lucas, M., & Medsger, T. A. (2001). Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases. Arthritis and Rheumatism, 44(7), 1663-6.
Gündüz OH, et al. Systemic Sclerosis With Renal Crisis and Pulmonary Hypertension: a Report of Eleven Cases. Arthritis Rheum. 2001;44(7):1663-6. PubMed PMID: 11465718.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases. AU - Gündüz,O H, AU - Fertig,N, AU - Lucas,M, AU - Medsger,T A,Jr PY - 2001/7/24/pubmed PY - 2001/8/17/medline PY - 2001/7/24/entrez SP - 1663 EP - 6 JF - Arthritis and rheumatism JO - Arthritis Rheum. VL - 44 IS - 7 N2 - OBJECTIVE: To describe a series of systemic sclerosis (SSc) patients with the unusual combination of scleroderma renal crisis (SRC) and pulmonary hypertension (PHT) without interstitial lung disease. METHODS: The medical records of 2,459 SSc patients in the University of Pittsburgh Scleroderma Databank first evaluated between 1972 and 1999 were reviewed. RESULTS: Eleven patients (0.45%) had both SRC and PHT. All had been evaluated since 1979, when angiotensin-converting enzyme (ACE) inhibitor therapy for SRC became available. Seven had SSc with limited cutaneous involvement, and 4 had SSc with diffuse cutaneous involvement. SRC occurred first in all patients except 1, in whom the onsets of SRC and PHT were simultaneous. SRC preceded PHT by a mean of 4.3 years. Four patients had anti-Th/To antibody, 5 had anti-RNA polymerase III antibody, 2 had anti-U3 RNP antibody, and none had anticentromere or antitopoisomerase I antibody. Ten of the 11 patients died, 8 from PHT. Ten patients were being treated with ACE inhibitor drugs when PHT developed. CONCLUSION: In SSc, SRC and PHT are not mutually exclusive complications. SSc patients surviving SRC who have serum antibodies to Th/To, RNA polymerase III, or U3 RNP are at increased risk to develop PHT. ACE inhibitor therapy did not prevent the development of PHT. SN - 0004-3591 UR - https://www.unboundmedicine.com/medline/citation/11465718/Systemic_sclerosis_with_renal_crisis_and_pulmonary_hypertension:_a_report_of_eleven_cases_ L2 - https://doi.org/10.1002/1529-0131(200107)44:7<1663::AID-ART290>3.0.CO;2-C DB - PRIME DP - Unbound Medicine ER -